Bone changes post-sleeve gastrectomy in relation to body mass and hormonal changes.

Prior research has shown that bariatric surgery can lead to changes in body composition and hormonal profiles. However, the specific effects on bone health in adolescents remain unclear. Established knowledge includes the role of sex steroids and bone turnover markers in bone metabolism. That uncertainty drove this study to explore longitudinal changes in bone density and hormonal levels after sleeve gastrectomy. No prior work had resolved the interplay between weight loss, lean mass reduction, and bone mineral density in youth. This gap motivated the investigation of bone health outcomes following a specific surgical intervention. The study aimed to address this gap by tracking changes over 24 months. The focus was on determining the mechanisms underlying impaired bone health in this population.

The aim of this study was to determine mechanisms contributing to impaired bone health in youth following sleeve gastrectomy. The specific problem addressed was the lack of understanding about how body mass and hormonal changes affect bone density post-surgery. The motivation was to identify potential targets for preventative or therapeutic interventions. The study sought to track longitudinal changes in bone mineral density and hormonal markers in adolescents. The participants included youth undergoing sleeve gastrectomy and non-surgical controls. The study design allowed for a direct comparison between surgical and non-surgical groups. The focus was on 24-month outcomes to capture long-term effects. The goal was to inform clinical strategies for preserving bone health in this population.

The study employed a 24-month longitudinal observational design. Participants included 23 youth undergoing sleeve gastrectomy and 30 non-surgical controls. The age range was 13 to 25 years. Subjects underwent fasting laboratory tests for bone turnover markers and sex hormones. Additional measurements included DXA scans for bone mineral density and body composition. High-resolution peripheral quantitative CT was used to assess volumetric BMD at the distal radius and tibia. Microfinite element analysis provided strength estimates. The groups were matched for age and BMI z-scores at baseline. The study tracked changes in bone density markers and hormonal levels over time.

Over 24 months, the SG group showed greater reductions in BMI z-scores compared to non-surgical controls. The SG group had lower spine, hip, and femoral neck aBMD Z-scores (P ≤ .012). Serum CTX and SHBG levels increased more in the SG group (P ≤ .039). Estrone and ghrelin levels decreased in the SG group (P ≤ .021). Among females, estrone and FAI decreased in the SG group compared to controls (P ≤ .022). Decreases in BMI and lean mass were associated with lower aBMD Z-scores in the SG group. Radial and tibial vBMD and failure load also decreased in the SG group. Among females, estrone decreases were linked to lower spine aBMD Z-scores and radial vBMD.

The authors propose that reductions in BMI, lean mass, and sex steroids over 24 months post-SG are associated with bone loss. These findings suggest potential targets for preventative or therapeutic interventions. The study highlights the importance of monitoring bone health in adolescents undergoing bariatric surgery. The results support the need for strategies to preserve bone density in this population. The findings are specific to the 24-month post-surgery period and the SG procedure. The authors suggest that hormonal changes may contribute to bone loss in youth. The study does not claim that these changes are essential but proposes a correlation. The results are limited to the observed population and timeframe.